These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 6651045)

  • 1. Acyclovir and neurologic manifestations.
    Auwerx J; Knockaert D; Hofkens P
    Ann Intern Med; 1983 Dec; 99(6):882-3. PubMed ID: 6651045
    [No Abstract]   [Full Text] [Related]  

  • 2. Neurological deterioration in the treatment of Herpes zoster: encephalitis or neurotoxic effect of acyclovir?
    De Cauwer H; Maes J; Viaene M; Janssen L; Belmans L
    Acta Neurol Belg; 2017 Mar; 117(1):395-397. PubMed ID: 27418364
    [No Abstract]   [Full Text] [Related]  

  • 3. More about acyclovir neurotoxicity in patients on haemodialysis.
    Gómez Campderá FJ; Verde E; Vozmediano MC; Valderrábano F
    Nephron; 1998; 78(2):228-9. PubMed ID: 9496746
    [No Abstract]   [Full Text] [Related]  

  • 4. Prospective epidemiologic study of painful and neurologic sequelae induced by herpes zoster in patients treated early with oral acyclovir.
    Bruxelle J
    Neurology; 1995 Dec; 45(12 Suppl 8):S78-9. PubMed ID: 8545032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Death Delusions and Myoclonus: Acyclovir Toxicity.
    Gentry JL; Peterson C
    Am J Med; 2015 Jul; 128(7):692-4. PubMed ID: 25784625
    [No Abstract]   [Full Text] [Related]  

  • 6. Acyclovir therapy for herpes zoster: advantages and adverse effects.
    Balfour HH
    JAMA; 1986 Jan; 255(3):387-8. PubMed ID: 3941520
    [No Abstract]   [Full Text] [Related]  

  • 7. Severe but reversible neurotoxicity from acyclovir.
    Cohen SM; Minkove JA; Zebley JW; Mulholland JH
    Ann Intern Med; 1984 Jun; 100(6):920. PubMed ID: 6721312
    [No Abstract]   [Full Text] [Related]  

  • 8. Trough plasma acyclovir concentrations and safety of oral acyclovir, 800 mg five times daily for 7 days in elderly patients with herpes zoster.
    Wood MJ; McKendrick MW; Freris MW; Jeal SC; Jones DA; Gilbert AM
    J Antimicrob Chemother; 1994 Jun; 33(6):1245-9. PubMed ID: 7928819
    [No Abstract]   [Full Text] [Related]  

  • 9. A pharmacokinetic and safety evaluation of a 28 day course of oral acyclovir in elderly patients with herpes zoster.
    Moss PJ; Wood MJ; Crooks RJ; Gallagher J; McKendrick MW
    J Antimicrob Chemother; 1995 Jul; 36(1):271-3. PubMed ID: 8537281
    [No Abstract]   [Full Text] [Related]  

  • 10. Neurotoxicity induced by the recommended acyclovir dosing in a dialysis patient with herpes zoster: A case letter.
    Kageyama R; Hashizume H
    J Dermatol; 2016 Mar; 43(3):339-40. PubMed ID: 26589129
    [No Abstract]   [Full Text] [Related]  

  • 11. Disseminated cutaneous herpes zoster complicated by acyclovir nephrotoxicity and successfully treated with brivudin.
    Aksoy B; Altaykan-Hapa A; Cengiz A; Mete Aksoy H; Atakan N
    Eur J Dermatol; 2010; 20(2):247-8. PubMed ID: 20103497
    [No Abstract]   [Full Text] [Related]  

  • 12. Oral acyclovir for herpes zoster.
    Drug Ther Bull; 1988 Nov; 26(24):93-4. PubMed ID: 3060343
    [No Abstract]   [Full Text] [Related]  

  • 13. Impaired renal function after bolus injections of acyclovir.
    Peterslund NA; Black FT; Tauris P
    Lancet; 1983 Jan; 1(8318):243-4. PubMed ID: 6130275
    [No Abstract]   [Full Text] [Related]  

  • 14. A randomized controlled trial of acyclovir versus netivudine for treatment of herpes zoster. International Zoster Study Group.
    Söltz-Szöts J; Tyring S; Andersen PL; Lucht RF; McKendrick MW; Diaz Perez JL; Shukla S; Fiddian AP
    J Antimicrob Chemother; 1998 May; 41(5):549-56. PubMed ID: 9630408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Varicella zoster virus reactivation in hemodialysis patients: manifestations, treatment, complications and outcome.
    Mesar I; Basić-Jukić N; Hudolin T; Katalinić L; Kes P
    Acta Clin Croat; 2011 Dec; 50(4):549-52. PubMed ID: 22649885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Severe neurologic toxicity from oral acyclovir].
    Ferré C; Espino A; Cruzado JM; Carratalá J
    Med Clin (Barc); 1992 May; 98(17):679. PubMed ID: 1598021
    [No Abstract]   [Full Text] [Related]  

  • 17. Drug treatment of herpes zoster.
    McGill J; James C; Hiscott P; Worstman T; Williams JH; Copplestone A; Larkin M
    Trans Ophthalmol Soc U K (1962); 1981; 101(1):3-5. PubMed ID: 6985235
    [No Abstract]   [Full Text] [Related]  

  • 18. Adverse effects of high-dose intravenous acyclovir in ambulatory patients with acute herpes zoster.
    Bean B; Aeppli D
    J Infect Dis; 1985 Feb; 151(2):362-5. PubMed ID: 3881542
    [No Abstract]   [Full Text] [Related]  

  • 19. [Severe central nervous system symptoms following oral administration of acyclovir in a patient with chronic renal failure: a case report].
    Niibori D; Fujisawa M; Matsuzaki M
    Hinyokika Kiyo; 1993 May; 39(5):459-61. PubMed ID: 8322628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative study of the efficacy and safety of valaciclovir versus acyclovir in the treatment of herpes zoster.
    Lin WR; Lin HH; Lee SS; Tsai HC; Huang CK; Wann SR; Chen YS; Chiang SC; Yen MY; Liu YC
    J Microbiol Immunol Infect; 2001 Jun; 34(2):138-42. PubMed ID: 11456360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.